Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorder of Skin Donor Site”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Not applicableEnded earlyNCT03624192
What this trial is testing

RES Prepared With RECELL® Compared to Conventional Care for Healing of Donor Sites in Ages 1-16 Years

Who this might be right for
Skin; Deformity
Avita Medical 3
Testing effectiveness (Phase 2)UnknownNCT02643680
What this trial is testing

Clinical Study of Biocellulose Wound Dressing Containing Silk Sericin and PHMB for STSG Donor Sites

Who this might be right for
WoundDisorder of Skin Donor Site
Chulalongkorn University 32
Early research (Phase 1)Active Not RecruitingNCT03420963
What this trial is testing

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

Who this might be right for
Recurrent Cutaneous MelanomaRecurrent Lip and Oral Cavity CarcinomaRecurrent Malignant Endocrine Neoplasm+25 more
M.D. Anderson Cancer Center 12
Testing effectiveness (Phase 2)Ended earlyNCT01715012
What this trial is testing

Study of ST266 in Diabetic Subjects With Deep Burns Managed With Skin Grafts

Who this might be right for
Third Degree BurnsDiabetes
Noveome Biotherapeutics, formerly Stemnion 1
Post-approval studies (Phase 4)UnknownNCT02400372
What this trial is testing

The Effect of Anti-bacterial Honey Dressing on the Healing of Split Thickness Skin Graft Donor Site

Who this might be right for
Disorder of Skin Donor Site
HaEmek Medical Center, Israel 135
Not applicableEnded earlyNCT00651716
What this trial is testing

T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Vanderbilt-Ingram Cancer Center 150
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Testing effectiveness (Phase 2)Study completedNCT00003887
What this trial is testing

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Not applicableUnknownNCT04299126
What this trial is testing

Efficacy and Safety of High Absorption Pad in Split-thickness Skin Graft Donor Site Wound

Who this might be right for
Disorder of Skin Donor Site
Chulalongkorn University 24
Early research (Phase 1)Study completedNCT01861509
What this trial is testing

BP-C1 in Metastatic Breast Cancer Patients

Who this might be right for
Metastatic Breast CancerStage IV Breast Cancer
Meabco A/S 10
Not applicableStudy completedNCT03209167
What this trial is testing

Comparing Patient Satisfaction of the Abdomen After DIEAP Procedure and Conventional Abdominoplasty

Who this might be right for
Donor Site ComplicationSatisfaction, PersonalBreast Cancer
Oslo University Hospital 44
Not applicableStudy completedNCT00900406
What this trial is testing

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Vanderbilt-Ingram Cancer Center 190
Not applicableStudy completedNCT01974583
What this trial is testing

Wound-healing Improvement by Resurfacing Split-Thickness Skin Donor Sites With Thin Split-thickness Grafting

Who this might be right for
Skin Graft DisorderDisorder of Skin Donor SiteWound Healing Disturbance of
Tang-Du Hospital 192
Testing effectiveness (Phase 2)Study completedNCT06766474
What this trial is testing

The Rule of Bupivacaine Hydrochloride in Skin Graft Donor Site

Who this might be right for
Skin Graft ComplicationsPain Management
Minia University 90
Not applicableLooking for participantsNCT05740033
What this trial is testing

Radial Forearm Donor Site Closure

Who this might be right for
Oral CancerOral Cavity CancerDonor Site Complication
University of British Columbia 120
Testing effectiveness (Phase 2)Looking for participantsNCT03779854
What this trial is testing

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Biphenotypic LeukemiaAcute LeukemiaAcute Leukemia of Ambiguous Lineage+14 more
Fred Hutchinson Cancer Center 68
Testing effectiveness (Phase 2)Study completedNCT00365287
What this trial is testing

Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer

Who this might be right for
Breast CancerKidney CancerLeukemia+3 more
Masonic Cancer Center, University of Minnesota 148
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Ended earlyNCT00602446
What this trial is testing

Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Breast CancerIron OverloadLeukemia+5 more
Masonic Cancer Center, University of Minnesota 4
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Load More Results